Andrulis IL - Search Results

1

Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry.

Smith LD, Tesoriero AA, Wong EM, Ramus SJ, O'Malley FP, Mulligan AM, Terry MB, Senie RT, Santella RM, John EM, Andrulis IL, Ozcelik H, Daly MB, Godwin AK, Buys SS, Fox S, Goldgar DE, Giles GG, Hopper JL, Southey MC. Smith LD, et al. Among authors: andrulis il. Breast Cancer Res. 2011 Jan 31;13(1):R14. doi: 10.1186/bcr2822. Breast Cancer Res. 2011. PMID: 21281505 Free PMC article.

2

Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53.

Ozçelik H, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Biotechniques. 1995 May;18(5):742-4. Biotechniques. 1995. PMID: 7619467 No abstract available.

3

Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer.

Mousses S, Ozçelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Mousses S, et al. Among authors: andrulis il. Hum Mol Genet. 1995 Jun;4(6):1089-92. doi: 10.1093/hmg/4.6.1089. Hum Mol Genet. 1995. PMID: 7655464

4

Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation.

Ozcelik H, Antebi YJ, Cole DE, Andrulis IL. Ozcelik H, et al. Among authors: andrulis il. Hum Genet. 1996 Sep;98(3):310-2. doi: 10.1007/s004390050212. Hum Genet. 1996. PMID: 8707299

5

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL. Done SJ, et al. Among authors: andrulis il. Cancer Res. 1998 Feb 15;58(4):785-9. Cancer Res. 1998. PMID: 9485035

6

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.

Ozçelik H, To MD, Couture J, Bull SB, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Int J Cancer. 1998 Jul 3;77(1):1-6. doi: 10.1002/(sici)1097-0215(19980703)77:1<1::aid-ijc1>3.0.co;2-y. Int J Cancer. 1998. PMID: 9639385 Free article.

7

Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.

Ozçelik H, Mousses S, Andrulis IL. Ozçelik H, et al. Among authors: andrulis il. Clin Cancer Res. 1995 Aug;1(8):907-12. Clin Cancer Res. 1995. PMID: 9816061

8

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.

Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL. Phillips KA, et al. Among authors: andrulis il. J Natl Cancer Inst. 1999 Mar 3;91(5):469-73. doi: 10.1093/jnci/91.5.469. J Natl Cancer Inst. 1999. PMID: 10070948

9

Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer.

Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, Andrulis IL, Lu J, Ho FC. Khoo US, et al. Among authors: andrulis il. Oncogene. 1999 Aug 12;18(32):4643-6. doi: 10.1038/sj.onc.1202847. Oncogene. 1999. PMID: 10467410

10

Mutation in the coding region of the BRCA1 gene leads to aberrant splicing of the transcript.

Ozcelik H, Nedelcu R, Chan VW, Shi XH, Murphy J, Rosen B, Andrulis IL. Ozcelik H, et al. Among authors: andrulis il. Hum Mutat. 1999;14(6):540-1. doi: 10.1002/(SICI)1098-1004(199912)14:6<540::AID-HUMU13>3.0.CO;2-C. Hum Mutat. 1999. PMID: 10571952 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

471 results

Search Page